Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals

Journal of Clinical Immunology

Volumn 22, Issue 2, 2002, Pages 106-115

  Wu, Xueling ^a   Jackson, Susan ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

HIV 1 infection; IgA subclasses; IgM; Saliva

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN SUBCLASS; VIRUS PROTEIN;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALIVA LEVEL; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CANDIDIASIS, ORAL; CD4 LYMPHOCYTE COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN M; LEUKOPLAKIA, HAIRY; MALE; MIDDLE AGED; SALIVA;

EID: 0036199497     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014435920321     Document Type: Article

References (44)

1. Mucosal Immunoglobulins
2. Selective transport of IgA: Cellular and molecular aspects
3. In defense of suffaces: Development of novel vaccines for IgA responses protective at portals of entry for microbial pathogens
4. Biological considerations in development of a human immunodeficiency virus vaccine
5. Serum IgA subclasses and molecular forms in HIV infection: Selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins
6. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals
7. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection
8. Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages
9. Antibody neutralization of HIV-1
10. Neutralization of HIV-1 by antibody
11. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer
12. Serum IgA-mediated neutralizalion of HIV type 1
13. Serum IgA from HIV-seropositive individuals mediates antibody dependent cellular cytotoxicity against HIV-infected cells
14. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients
15. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects
16. Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype
17. Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex
18. HIV-specific IgA antibodies in tears of children with AIDS or at risk of AIDS
19. Antibodies to human immunodeficiency virus in the breast milk of healthy seropositive women
20. Infective and anti-infective properties of breast milk from HIV-1-infected women
21. Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection
22. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women
23. HIV excretion patterns and specific antibody response in body fluids
24. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women
25. Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS
26. Antibodies to human immunodeficiency virus in the semen of heterosexual men
27. A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men
28. Detection of rectal antibodies to HIV-1 by a sensitive chemiluminescent western blot immunodetection method
29. Secretory and serum IgA are inversely altered in AIDS patients
30. Both IgA subclasses are reduced in parotid saliva from patients with AIDS
31. IgA subclasses in HIV disease: Dichotomy between raised levels in serum and decreased secretion rates in saliva
32. Salivary defence factor concentrations in relation to oral and general parameters in HIV positive patients
33. Immunoglobulin A (IgA), IgA 1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS
34. Immunoglobulin class- and subclass-specific HIV antibody detection in serum and CSF specimens by ELISA and western blot
35. Isotype restriction of the antibody response to human immunodeficiency virus
36. Detection of anti-HIV-1 immunoglobulin M antibodies in patients with serologically proved HIV-1 infection
37. Reflex secretion of human parotid gland
38. Jacalin: A jackfruit (Artocarpus heterophyllus) seed-derived lectin of versatile applications in immunobiological research
39. Plasma and salivary IgG subclasses in HIV type 1 infection: Evidence of both transudation and local synthesis of IgG in parotid saliva
40. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects
41. IgG subclass responses to human immunodeficiency virus-1 antigens: Lack of IgG 2 response to gp41 correlates with clinical manifestation of disease
42. Pathogenesis of human immunodeficiency virus infection
43. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome
44. Hypergammaglobulinemia associated with human immunodeficiency virus infection